Fig. 5From: Investigation of anti-osteoporosis mechanisms of Rehmanniae Radix Preparata based on network pharmacology and experimental verificationMolecular docking model diagram. a Molecular docking of AKT1 with stigmasterol. b Molecular docking of AKT1 with sitosterol. c Molecular docking of MAPK1 with stigmasterol. d Molecular docking of MAPK1 with sitosterol. e Molecular docking of ESR1 with stigmasterol. f Molecular docking of SRC with stigmasterol. g Molecular docking of MMP9 with stigmasterol. h Molecular docking of ESR1 with sitosterolBack to article page